Therapeutic Asset Ratings
130 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
HER2-positive Breast Cancer
SWOG Cancer Research Network
P4
BB
(71)
TRASTUZUMAB
HER2-positive Breast Cancer
SWOG Cancer Research Network
P4
BB
(70)
Capecitabine
HER2-positive Breast Cancer
MedSIR
P4
BB
(68)
Cyclophosphamide
HER2-positive Breast Cancer
National University Hospital, Singapore
P3
BB
(68)
Docetaxel
HER2-positive Breast Cancer
Ohio State University Comprehensive Cancer Center
P3
BB
(68)
Vinorelbine
HER2-positive Breast Cancer
Fudan University
P3
BB
(68)
Eloxatin
HER2-positive Breast Cancer
MedSIR
P4
BB
(66)
Pyrotinib
HER2-positive Breast Cancer
Peking University People's Hospital
P4
BB
(66)
Trastuzumab Emtansine
HER2-positive Breast Cancer
SWOG Cancer Research Network
P4
BB
(66)
Carboplatin
HER2-positive Breast Cancer
Rutgers, The State University of New Jersey
P3
BB
(66)
Epirubicin
HER2-positive Breast Cancer
Ohio State University Comprehensive Cancer Center
P3
BB
(66)
Inno-206
HER2-positive Breast Cancer
Shanghai JMT-Bio Inc.
P3
BB
(66)
Zanidatamab
HER2-positive Breast Cancer
MedSIR
P3
BB
(65)
rc48-adc
HER2-positive Breast Cancer
Fudan University
P4
BB
(64)
Shr-A1811
HER2-positive Breast Cancer
Haihua Yuan
P4
BB
(64)
Lapatinib
HER2-positive Breast Cancer
Deraya University
P3
B
(63)
Trastuzumab Deruxtecan
HER2-positive Breast Cancer
SWOG Cancer Research Network
P3
B
(63)
T-Dxd
HER2-positive Breast Cancer
Peking University Cancer Hospital & Institute
P2/3
B
(63)
FULVESTRANT
HER2-positive Breast Cancer
Sun Yat-sen University
P3
B
(62)
Letrozole
HER2-positive Breast Cancer
Sun Yat-sen University
P3
B
(62)
Zoladex
HER2-positive Breast Cancer
Fudan University
P3
B
(62)
Palbociclib
HER2-positive Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
P2
B
(62)
ANTI-HER2 ANTIBODY-DRUG CONJUGATE A166
HER2-positive Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
P3
B
(60)
Atezolizumab
HER2-positive Breast Cancer
Samsung Medical Center
P3
B
(60)
Bl-M07D1
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P3
B
(60)
Showing 1 to 25 of 130 assets
Previous
Page 1 of 6
Next
